Letters


 

Today, Matt Salo, executive director of the National Association of Medicaid Directors, gave testimony before the Energy and Commerce Committee, Subcommittee on Health on "Examining the Administration's Approval of Medicaid Demonstration Projects."

NAMD submits comments to CMS on the Draft 2016 Medicaid Managed Care Rate Development Guide

NAMD submitted comments to the Centers for Medicare and Medicaid Services on the proposed rule on the Application of Mental Health Parity Requirements to Coverage Offered by Medicaid Managed Care Organizations, the Children's Health Insurance Program (CHIP), and Alternative Benefit Plans.

NAMD sent a letter to the Health Resources and Services Administration (HRSA) and the Centers for Medicare and Medicaid Services (CMS) to share our recent white paper discussing operational challenges in Medicaid's interaction with the 340B drug discount program. The white paper is available here.

The National Association of Medicaid Directors sent a letter to the leaders of the House Energy and Commerce Committee regarding the impact to the Medicaid program from federal legislative efforts to incentivize and expedite high-cost cure-like pharmaceutical treatments and devices. 

The National Association of Medicaid Directors submitted a letter to the Centers for Medicare and Medicaid Services Acting Administrator Slavitt. The letter acknowledges progress made to improve Medicaid and Exchange interactions and calls for additional steps to improve the beneficiary experience and efficiency of operations. 

NAMD submitted comments to the Centers for Medicare and Medicaid Services in response to the Medicare Advantage Capitation Rates, Part C and Part D Payment Policies and 2016 Call Letter. NAMD urges CMS to expedite action to better support a viable delivery system for the Medicare-Medicaid dual eligible population. 

NAMD submitted comments to the Substance Abuse and Mental Health Services Administration (SAMHSA) on the draft criteria for the state-certified community behavioral health clinic demonstration enacted under Sec. 223 of the Protecting Access to Medicare Act of 2014. The letter focuses on the need to finalize a CCBHC framework that is flexible enough to support states and clinics in enhancing care for those with behavioral health conditions, regardless of their starting place.

NAMD submitted comments to the Centers for Medicare and Medicaid Services to inform the development of the prospective payment system (PPS) for the certified community behavioral health clinic (CCBHC) demonstration. This demonstration, which was enacted under the Protecting Access to Medicare Act, will be a 2-year pilot project under which eight states will develop a PPS for CCBHCs.

NAMD submitted comments to the Substance Abuse and Mental Health Services Administration (SAMHSA) on the criteria for the state-certified community behavioral health clinic (CCBHC) demonstration enacted under Sec. 223 of the Protecting Access to Medicare Act of 2014. The comments focus on maximizing participation and success for those states interested in leveraging this opportunity to build capacity and advance practice transformation in their behavioral health systems.

Pages

© 2012 National Association of Medicaid Directors
444 North Capitol Street, Suite 524
Washington, D.C. 20001
202.403.8620